| 1 |
Mycosis Fungoides and Sézary Syndrome: An Update. ( 30497668
)
|
Larocca C...Kupper T
|
2019 |
| 2 |
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. ( 29947731
)
|
|
2018 |
| 3 |
Local radiation for cutaneous T-cell lymphoma other than mycosis fungoides and Sézary syndrome. ( 30180750
)
|
Shikama N
|
2018 |
| 4 |
Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: a concise review. ( 30525754
)
|
Johnson WT...Alpdogan O
|
2018 |
| 5 |
Treatment of mycosis fungoides and Sezary syndrome with romidepsin: a series of 32 cases of the French Study Group for Cutaneous Lymphoma. ( 30298903
)
|
Deschamps O...French Study Group for Cutaneous Lymphoma
|
2018 |
| 6 |
Potential Association of Anti-CCR4 Antibody Mogamulizumab and Graft-vs-Host Disease in Patients With Mycosis Fungoides and Sézary Syndrome. ( 29800117
)
|
Dai J...Kim YH
|
2018 |
| 7 |
Developments in the understanding of blood involvement and stage in mycosis fungoides/Sezary syndrome. ( 30017383
)
|
Scarisbrick JJ...Vermeer M
|
2018 |
| 8 |
Infectious events and associated risk factors in mycosis fungoides/Sézary syndrome: a retrospective cohort study. ( 30098016
)
|
Blaizot R...Pham-Ledard A
|
2018 |
| 9 |
Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients. ( 30176169
)
|
Lebowitz E...Myskowski PL
|
2018 |
| 10 |
Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndrome. ( 30213403
)
|
Prince HM...Querfeld C
|
2018 |
| 11 |
Infections in mycosis fungoides and Sézary syndrome are a frequent cause of morbidity and contribute to mortality. What can be done? ( 30508233
)
|
Scarisbrick JJ
|
2018 |
| 12 |
Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome. ( 28925057
)
|
Sakamoto M...Sato S
|
2018 |
| 13 |
The "Duvic regimen" for erythrodermic flares secondary to Staphylococcus aureus in mycosis fungoides and Sézary syndrome. ( 29152728
)
|
Lewis DJ...Duvic M
|
2018 |
| 14 |
Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome. ( 29204699
)
|
Geskin LJ...Falo LD
|
2018 |
| 15 |
Therapeutic and prognostic significance of PARP-1 in advanced mycosis fungoides and Sezary syndrome. ( 29205518
)
|
Lemchak D...Akilov OE
|
2018 |
| 16 |
Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force. ( 29477101
)
|
Scarisbrick JJ...Vermeer MH
|
2018 |
| 17 |
The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study. ( 29543675
)
|
Gru AA...Kim YH
|
2018 |
| 18 |
Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome. ( 29572582
)
|
Photiou L...Miles Prince H
|
2018 |
| 19 |
Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome. ( 29605670
)
|
Oka T...Sato S
|
2018 |
| 20 |
Atypical Varicella-Zoster Kaposi Varicelliform Eruption in Sézary Syndrome. ( 30211729
)
|
Gottesman SP...Freeman BB
|
2018 |
| 21 |
Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab. ( 30277017
)
|
Ricci C...Sabattini E
|
2018 |
| 22 |
Long-term complete remission of early hematological relapse after discontinuation of immunosuppressants following allogeneic transplantation for Sezary syndrome. ( 30283619
)
|
Hosoi H...Sonoki T
|
2018 |
| 23 |
Association of autoimmunity and long-term complete remission in patients with Sézary syndrome treated with mogamulizumab. ( 30328116
)
|
Bonnet P...de Masson A
|
2018 |
| 24 |
Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome. ( 30356161
)
|
Torrey H...Faustman DL
|
2018 |
| 25 |
Sézary syndrome without erythroderma: A case report and review of published work. ( 30379353
)
|
Kamijo H...Sato S
|
2018 |
| 26 |
Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome. ( 30518749
)
|
Caprini E...Russo G
|
2018 |
| 27 |
Sezary syndrome, recent biomarkers and new drugs. ( 30525758
)
|
Cristofoletti C...Russo G
|
2018 |
| 28 |
Sézary syndrome with T/NK phenotype: A variant phenotype or a distinct clinical entity? ( 27145066
)
|
Matos DM...Falc?o RP
|
2018 |
| 29 |
Different genetic alteration of A20 in a Sézary syndrome case with Vα2-Jα22 T cell clone. ( 28296250
)
|
Zhou L...Li Y
|
2018 |
| 30 |
Sézary syndrome managed with histone deacetylase inhibitor followed by anti-CCR4 monoclonal antibody. ( 29327377
)
|
Numata T...Okubo Y
|
2018 |
| 31 |
SNF5 deficiency induces apoptosis resistance by repressing SATB1 expression in Sézary syndrome. ( 29334836
)
|
Li Y...Wang X
|
2018 |
| 32 |
Chronic activation profile of circulating CD8+ T cells in Sézary syndrome. ( 29423061
)
|
Torrealba MP...Sanches JA
|
2018 |
| 33 |
Is HERV-K and HERV-W expression regulated by mir-155 in Sézary syndrome? ( 29582620
)
|
Bergallo M...Fierro MT
|
2018 |
| 34 |
Sézary syndrome-clinical and histopathologic features, differential diagnosis, and treatment. ( 29719016
)
|
Spicknall KE
|
2018 |
| 35 |
Paraneoplastic arthritis in a patient with Sézary syndrome. ( 29726614
)
|
Kuzumi A...Sato S
|
2018 |
| 36 |
Sezary syndrome manifesting as posttransplant lymphoproliferative disorder. ( 29761072
)
|
Afiat TP...Sokol L
|
2018 |
| 37 |
Onychodystrophy in Sézary syndrome. ( 29920318
)
|
Damasco FM...Akilov OE
|
2018 |
| 38 |
Sézary Syndrome Presenting With Renal Involvement. ( 29941220
)
|
Wickenden K...Burton JO
|
2018 |
| 39 |
Sézary syndrome in an anti-human T-cell lymphotropic virus type 1 seropositive carrier. ( 29952024
)
|
Baba N...Kanekura T
|
2018 |
| 40 |
Single-cell heterogeneity in Sézary syndrome. ( 30139925
)
|
Buus TB...?dum N
|
2018 |
| 41 |
Aprepitant for the Treatment of Pruritus in Sézary Syndrome: A Randomized Crossover Clinical Trial. ( 30140912
)
|
Zic JA...Brown NJ
|
2018 |
| 42 |
Remarkable Advances in the Management of Mycosis Fungoides and the Sezary Syndrome. ( 28423383
)
|
Hoppe R.T.
|
2017 |
| 43 |
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. ( 28961843
)
|
Quaglino P....Kim Y.
|
2017 |
| 44 |
Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS). ( 28466385
)
|
Atilla E....Ozcan M.
|
2017 |
| 45 |
CD4-Positive T-Cell Large Granular Lymphocytosis Mimicking Sezary Syndrome in a Patient With Mycosis Fungoides. ( 28441377
)
|
Zhang L....Sokol L.
|
2017 |
| 46 |
Transformation of Mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. ( 28533196
)
|
|
2017 |
| 47 |
Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome. ( 28271282
)
|
Corbin ZA...Nagpal S
|
2017 |
| 48 |
Mycosis Fungoides and Sezary Syndrome. ( 28340880
)
|
Foss FM...Girardi M
|
2017 |
| 49 |
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. ( 28365528
)
|
Trautinger F...Knobler R
|
2017 |
| 50 |
Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome. ( 28540671
)
|
Berg S...Kim EJ
|
2017 |
